Skip to content

CFAASP Resources

We convert surveillance results into useful information for participating feedlot producers and veterinarians, the Canadian beef industry, bovine practitioners, researchers, Public Health Agency of Canada, and other stakeholders (e.g., reports, infographics/fact sheets, webinars, podcasts).

Back to search results



Publish Date: Jan/20/2025
Document Date: Jan/20/2025

Parenteral Antimicrobial Use in Canadian Feedlot Cattle CFAASP 2023

Share:
In 2023, AMU (antimicrobial use) data were collected from129,872 head of cattle in 393 randomly selected closed production lots from 26 finishing feedlots in AB, SK, and ON. Approximately 50% of the cattle were 1) calves vs. yearlings,2) steers vs. heifers, and 3) at high risk for bovine respiratory disease (BRD) on feedlot entry. Parenteral (injectable (4.5%), oral boluses (0.5%))antimicrobials represented 5% of all AMU. In 2023, parenteral AMU was similar in calves and yearlings although types of antimicrobials used varied. AMU increased in yearlings from 2019 to 2023.